Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Yali Liang, MD

Director
Jazz Pharmaceuticals
Newtown, Pennsylvania, United States

Yali Liang, MD, MS, MPH, Director of Clinical Pharmacology & Pharmacometrics, Jazz Pharmaceuticals

Yali is currently a Director in Global Clinical Pharmacology & Pharmacometrics at Jazz Pharmaceuticals. She serves as the clinical pharmacology and pharmacometrics expert for various assets across oncology and neuroscience portfolios at Jazz. Prior to joining Jazz, she worked at Bristol Myers Squibb as a clinical pharmacologist focusing on immuno-oncology therapeutic agents. Prior to BMS, Yali worked at Global Pharmacometrics at Pfizer. Yali has over 14 years of drug development experience in pharmaceutical industry and has contributed to the successful approval of Opdualag (nivolumab and relatlimab combination therapy), Opdivo, avelumab, ertugliflozin, ALO-2 etc.
Yali holds a MD and MPH from Tongji Medical University in China, MS in Pharmacometrics from University of Maryland, and MS in Pharmaceutical Science from University of Kentucky.

Disclosure(s): No financial relationships to disclose

Presentation(s):